ANAVEX LIFE SCIENCES CORP. Operating Income

Quick Answer

ANAVEX LIFE SCIENCES CORP. reported Operating Income of -$51.41 million for fiscal year 2025.

ANAVEX LIFE SCIENCES CORP. Operating Income — Annual History

Fiscal Year Operating Income YoY Change
2025 -$51.41M +2.8%
2024 -$52.88M +5.2%
2023 -$55.76M -9.4%
2022 -$50.99M -21.4%
2021 -$42.00M -35.1%
2020 -$31.09M -947.1%
2014 -$2.97M -38.9%
2013 -$2.14M +50.5%
2012 -$4.32M +30.1%
2011 -$6.18M -9.4%
2010 -$5.65M

Quarterly Operating Income

Quarter Ending Operating Income YoY QoQ
December 31, 2025 -$6.78M +50.1% +53.1%
June 30, 2025 -$14.46M +1.0% -15.6%
March 31, 2025 -$12.51M +0.9% +7.9%
December 31, 2024 -$13.59M -19.5% +6.9%
June 30, 2024 -$14.60M -7.9% -15.7%
March 31, 2024 -$12.62M +11.0% -11.0%
December 31, 2023 -$11.38M +26.0% +15.9%
June 30, 2023 -$13.53M -8.6% +4.6%
  • ANAVEX LIFE SCIENCES CORP. showed an increase of +2.8% in Operating Income compared to the prior fiscal year.
  • Over the 2010–2025 period, ANAVEX LIFE SCIENCES CORP.’s operating income has declined by 810.2% (from -$5.65 million to -$51.41 million).
  • The most recent figure is from ANAVEX LIFE SCIENCES CORP.’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 25, 2025.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment